Watch highlights from the Virtual Cancer and Immunology Research Summit 2021

Thousands of scientists from across the world have joined world-class speakers and leading manufacturers online to explore the major new developments in cancer and immunology research.

From technological innovations to novel techniques and top resources to advance your work, the successful Virtual Cancer and Immunology Research Summit 2021 covered hot topics ranging from immunology and COVID-19, CAR T-cell therapy and immunotherapy to genomic research and CRISPR technology, cancer diagnostics, cancer imaging and more.

First launched a year ago, the SelectScience^® Virtual Summits offer a crucial platform for the science industry to continue to connect at this critical time, featuring eminent speakers, technology workshops, interactive booths from leading brands and dedicated networking sessions.

Explaining the significance of the events, Summit speaker Dr. Kirk McManus, University of Manitoba, said: “I believe it is incredibly important, especially during the COVID-19 pandemic, to continue to present and share our team’s research findings with the global research community, stakeholders and in particular, the general public. The SelectScience virtual conference provides an outstanding platform in which to engage a diverse audience and receive questions and feedback that will help shape our future cancer research efforts.”

Missed the live event? Don't worry - all presentations are now available to view on demand>>

More than 5,500 scientists attended ‘live’ webinar presentations and virtual resource booths over the two-day event, which featured a total of 23 compelling presentations each drawing crowds of up to 530 live attendees.

Just a few of the talks available to watch on demand include:

• Multi-modality approach to predicting and monitoring immunotherapy response and resistance – Dr. Genevieve Boland, Harvard Medical School [Keynote]
• Overcoming T cell homing challenges in CAR-T cell cancer therapies - Prof. Ann Ager, Cardiff University
• Targeting metabolism to treat pancreatic cancer - Dr. Chris Halbrook, University of California, Irvine
• The impact of COVID-19 on pediatric medulloblastoma: A global response - Dr. Noelle Cutter, New York’s Molloy College
• Profiling of the immune system of multiple myeloma patients at diagnosis and after treatment using mass cytometry by time-of-flight (CyTOF) - Dr. Komal Kumar Javarappa, University of Helsinki
• Proteomic analysis to predict response to immunotherapy - Dr. Ofer Sharon, OncoHost
• Identifying and targeting chromosome instability genes in cancer - Dr. Kirk McManus, University of Manitoba
• PD-1 mechanism of action: What do we know? - Prof. Adil Daud, University of California
• Pharmacokinetic services: Tools for cancer research - Samer Sansil, Moffitt Cancer Center

SelectScience CEO Kerry Parker said: “It’s been fantastic to be able to offer a platform to these speakers right at the forefront of their fields and we would like to thank them all for taking the time to share their work with our audience.”

Samer Sansil

Moffitt Cancer Center & Summit speaker

A number of leading manufacturers presented their latest technologies available in the field, including Sartorius, Agilent, Thermo Fisher Scientific, Olink, GenScript, Charles River, Merck, Bertin Instruments, Bio-Techne, Bruker, Purigen Biosystems, Bethyl Laboratories, Fortis Life Sciences, Sony and Twist Bioscience. All presentations are now available on demand.

Attendees were able to collect a virtual swag bag of useful resources completely free of charge. Featured highlights from the summit include:

• Revolutionary insight into cancer hallmarks with real-time live-cell analysis
• Magnis NGS Prep System key features
• Breakthroughs in immunotherapy
• Development of next-generation antibodies for therapeutics
• Oncology drug discovery capabilities

Missed the live event? Don't worry - all presentations are now available to view on demand>>